Form 8-K · Current report
Ventas 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000740260
- Accession no.
- 0000740260-26-000022
Summary
Ventas reported second-quarter 2026 results with Normalized FFO of $0.97 per share, up 9% year-over-year, and raised its full-year 2026 guidance, while increasing its expected 2026 senior housing investment volume to $4.5 billion from $3 billion, according to Chairman and CEO Debra A. Cafaro.
Key points
- Ventas reported second-quarter 2026 Attributable Net Income per share of $0.14 and Normalized FFO per share of $0.97, up 9% year-over-year.
- Total Company Same-Store Cash NOI grew 10% year-over-year and the Senior Housing Operating Portfolio Same-Store Cash NOI grew 16%.
- Ventas closed $3.4 billion of senior housing investments year to date and is increasing its 2026 investment volume expectations to $4.5 billion from $3 billion.
- Ventas raised its full-year 2026 Normalized FFO guidance range to $3.85-$3.90 per share and reported Net Debt-to-Further Adjusted EBITDA of 4.7x.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On July 29, 2026, Ventas, Inc. (the “Company”) issued a press release announcing its results of operations for the quarter ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Item 2.02 by reference. The information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” with the U.S. Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Securities…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.